Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

PPAR‐gamma‐mediated neuroprotection in a chronic mouse model of Parkinson’s disease

Schintu, N., Frau, L., Ibba, M., Caboni, P., Garau, A., Carboni, E., & Carta, A. R. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06657.x · Cited by 202

Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon

Peyrin‐Biroulet, L., Beisner, J., Wang, G., Nuding, S., Oommen, S. T., Kelly, D., Parmentier-Decrucq, E., Dessein, R., Mérour, E., Chavatte, P., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905745107 · Cited by 199

Differentiation of Trophoblast Giant Cells and Their Metabolic Functions Are Dependent on Peroxisome Proliferator-Activated Receptor β/δ

Nadra, K., Anghel, S. I., Joye, E., Tan, N. S., Modak, S. B., Trono, D., Wahli, W., & Desvergne, B. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.3266-3281.2006 · Cited by 199

Cross-Talk between Peroxisome Proliferator-Activated Receptor (PPAR) α and Liver X Receptor (LXR) in Nutritional Regulation of Fatty Acid Metabolism. II. LXRs Suppress Lipid Degradation Gene Promoters through Inhibition of PPAR Signaling

Ide, T., Shimano, H., Yoshikawa, T., Yahagi, N., Amemiya-Kudo, M., Matsuzaka, T., Nakakuki, M., Yatoh, S., Iizuka, Y., Tomita, S., et al. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0191 · Cited by 204

An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancer

Gelman, L., Fruchart, J., & Auwerx, J. H. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050345 · Cited by 199

Possible impact of phthalates on infant reproductive health

Lottrup, G., Andersson, A., Leffers, H. C. B., Mortensen, G. K., Toppari, J., Skakkebæk, N. E., & Main, K. M. (2006) · International Journal of Andrology · doi:10.1111/j.1365-2605.2005.00642.x · Cited by 198

Peroxisome proliferator-activated receptor agonists

Willson, T. M., & Wahli, W. (1997) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(97)80015-4 · Cited by 197

Peroxisome proliferator-activated receptor γ transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells

Galli, A., Crabb, D., Price, D., Ceni, E., Salzano, R., Surrenti, C., & Casini, A. (2000) · Hepatology · doi:10.1002/hep.510310117 · Cited by 197

Role of peroxisome proliferator-activated receptor γ and retinoid X receptor heterodimer in hepatogastroenterological diseases

Dubuquoy, L., Dharancy, S., Nutten, S., Pettersson, S., Auwerx, J. H., & Desreumaux, P. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11395-x · Cited by 201

Thiazolidinediones and insulin resistance: Peroxisome proliferatoractivated receptor γ activation stimulates expression of the CAP gene

Ribon, V., Johnson, J. H., Camp, H. S., & Saltiel, A. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14751 · Cited by 196

Functional Role of PPARs in Ruminants: Potential Targets for Fine-Tuning Metabolism during Growth and Lactation

Bionaz, M., Chen, S., Khan, M. J., & Loor, J. J. (2013) · PPAR Research · doi:10.1155/2013/684159 · Cited by 202

Kinase independent function of EphB receptors in retinal axon pathfinding to the optic disc from dorsal but not ventral retina

Birgbauer, E., Cowan, C. A., Sretavan, D. W., & Henkemeyer, M. J. (2000) · Development · doi:10.1242/dev.127.6.1231 · Cited by 195

Role of the peroxisome proliferator‐activated receptor‐γ (PPAR‐γ) and its natural ligand 15‐deoxy‐Δ12,14‐prostaglandin J2in the regulation of microglial functions

Bernardo, A., Levi, G., & Minghetti, L. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00110.x · Cited by 222

Peroxisome Proliferator-Activated Receptor γ Activators Inhibit Cardiac Hypertrophy in Cardiac Myocytes

Yamamoto, K., Ohki, R., Lee, R. T., Ikeda, U., & Shimada, K. (2001) · Circulation · doi:10.1161/hc4001.097186 · Cited by 192

Dual activation of PPARα and PPARγ by mono-(2-ethylhexyl) phthalate in rat ovarian granulosa cells

Lovekamp-Swan, T., Jetten, A. M., & Davis, B. J. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00423-9 · Cited by 191

Peroxisome proliferator-activated receptor beta/delta (PPARβ/δ) acts as regulator of metabolism linked to multiple cellular functions

Wagner, K., & Wagner, N. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.12.001 · Cited by 198

Fenofibrate, a PPARα agonist, has renoprotective effects in mice by enhancing renal lipolysis

Tanaka, Y., Kume, S., Araki, S., Isshiki, K., Chin‒Kanasaki, M., Sakaguchi, M., Sugimoto, T., Koya, D., Haneda, M., Kashiwagi, A., et al. (2011) · Kidney International · doi:10.1038/ki.2010.530 · Cited by 195

Peroxisome Proliferator-Activated Receptor-γ Modulates Differentiation of Human Trophoblast in a Ligand-Specific Manner1

Schaiff, W. T., Carlson, M. G., Smith, S. D., Levy, R., Nelson, D. M., & Sadovsky, Y. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.10.6885 · Cited by 189

Isolation and Characterization of Peroxisome Proliferator-activated Receptor (PPAR) Interacting Protein (PRIP) as a Coactivator for PPAR

Zhu, Y., Kan, L., Qi, C., Kanwar, Y. S., Yeldandi, A. V., Rao, M. S., & Reddy, J. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13510 · Cited by 189

Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-γ

Niino, M., Iwabuchi, K., Kikuchi, S., Ato, M., Morohashi, T., Ogata, A., Tashiro, K., & Onoé, K. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00285-5 · Cited by 188

The peroxisome proliferator-activated receptor alpha is a phosphoprotein: regulation by insulin

Shalev, A., Siegrist-Kaiser, C. A., Yen, P. M., Wahli, W., Burger, A., Chin, W. W., & Meier, C. A. (1996) · Endocrinology · doi:10.1210/endo.137.10.8828512 · Cited by 191

PPARγ-Ligands Inhibit Migration Mediated by Multiple Chemoattractants in Vascular Smooth Muscle Cells

Goetze, S., Xi, X.-P., Kawano, H., Gotlibowski, T., Fleck, E., Hsueh, W. A., & Law, R. E. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199905000-00018 · Cited by 184

Immunoregulatory and anti-inflammatory effects of n-3 polyunsaturated fatty acids

Calder, P. C. (1998) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x1998000400002 · Cited by 189

The Role of PPAR-δ in Metabolism, Inflammation, and Cancer: Many Characters of a Critical Transcription Factor

Liu, Y., Colby, J. K., Zuo, X., Jaoude, J. C., Wei, D., & Shureiqi, I. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113339 · Cited by 196

Troglitazone Antagonizes Tumor Necrosis Factor-α-induced Reprogramming of Adipocyte Gene Expression by Inhibiting the Transcriptional Regulatory Functions of NF-κB

Ruan, H., Pownall, H. J., & Lodish, H. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303141200 · Cited by 188

Phthalate exposure and male infertility

Latini, G., Vecchio, A. D., Massaro, M., Verrotti, A., & Felice, C. D. (2006) · Toxicology · doi:10.1016/j.tox.2006.07.011 · Cited by 185

PPARs: Regulators of Metabolism and As Therapeutic Targets in Cardiovascular disease. Part I: PPAR-α

Han, L., Shen, W., Bittner, S., Kraemer, F. B., & Azhar, S. (2017) · Future Cardiology · doi:10.2217/fca-2016-0059 · Cited by 194

Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency

Takeda, K., Toda, K., Saibara, T., Nakagawa, M., Saika, K., Onishi, T., Sugiura, T., & Shizuta, Y. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1760237 · Cited by 182

Peroxisome Proliferator-Activated Receptors Increase Human Sebum Production

Trivedi, N. R., Cong, Z., Nelson, A. M., Albert, A. J., Rosamilia, L. L., Sivarajah, S., Gilliland, K. L., Liu, W., Mauger, D. T., Gabbay, R. A., et al. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700336 · Cited by 184

Kefir alleviates obesity and hepatic steatosis in high-fat diet-fed mice by modulation of gut microbiota and mycobiota: Targeted and untargeted community analysis with correlation of biomarkers

Kim, D.-H., Kim, H., Jeong, D., Kang, I.-B., Chon, J.-W., Kim, H.-S., Song, K.-Y., & Seo, K.-H. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.02.014 · Cited by 179

Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases

Decara, J. M., Rivera, P., López-Gambero, A. J., Serrano, A., Pavón, F. J., Baixerás, E., de Fonseca, F. R., & Suárez, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00730 · Cited by 186

Molecular mechanisms of lysophosphatidic acid action

Tigyi, G., & Parrill, A. L. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00035-3 · Cited by 181

Peroxisome Proliferator–Activated Receptor Activators Inhibit Lipopolysaccharide-Induced Tumor Necrosis Factor-α Expression in Neonatal Rat Cardiac Myocytes

Takano, H., Nagai, T., Asakawa, M., Toyozaki, T., Oka, T., Komuro, I., Saito, T., & Masuda, Y. (2000) · Circulation Research · doi:10.1161/01.res.87.7.596 · Cited by 182

Metabolomic study of cisplatin-induced nephrotoxicity

Portilla, D., Li, S., Nagothu, K. K., Megyesi, J. K., Kaissling, B., Schnackenberg, L. K., Safirstein, R. L., & Beger, R. D. (2006) · Kidney International · doi:10.1038/sj.ki.5000433 · Cited by 181

Loss of the Peroxisome Proliferation-activated Receptor gamma (PPARγ) Does Not Affect Mammary Development and Propensity for Tumor Formation but Leads to Reduced Fertility

Cui, Y., Miyoshi, K., Claudio, E., Siebenlist, U. K., Gonzalez, F. J., Flaws, J. A., Wagner, K., & Hennighausen, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200186200 · Cited by 180

Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization.

Murata, T., He, S., Hangai, M., Ishibashi, T., Xi, X. P., Kim, S., Hsueh, W. A., Ryan, S. J., Law, R. E., & Hinton, D. R. (2000) · PubMed · Cited by 178

Effects of L-carnitine against oxidative stress in human hepatocytes: involvement of peroxisome proliferator-activated receptor alpha

Li, J., Wang, Q., Luan, H., Kang, Z.-C., & Wang, C. (2012) · Journal of Biomedical Science · doi:10.1186/1423-0127-19-32 · Cited by 183

Metabolic and genetic regulation of cardiac energy substrate preference

Kodde, I. F., van der Stok, J., Smolenski, R. T., & de Jong, J. W. (2006) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2006.09.014 · Cited by 190

Phosphorylation of PPARs: from molecular characterization to physiological relevance

Diradourian, C., Girard, J. R., & Pégorier, J. P. (2004) · Biochimie · doi:10.1016/j.biochi.2004.11.010 · Cited by 182

The Metabolic Syndrome: Peroxisome Proliferator-Activated Receptor γ and Its Therapeutic Modulation

Gurnell, M., Savage, D. B., Chatterjee, K., & O’Rahilly, S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030435 · Cited by 178

Peroxisome proliferator-activated receptors (PPARS): regulators of gene expression in heart and skeletal muscle

Gilde, A. J., & Van Bilsen, M. (2003) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2003.01161.x · Cited by 178

Cloning and identification of mouse steroid receptor coactivator-1 (mSRC-1), as a coactivator of peroxisome proliferator-activated receptor gamma.

Zhu, Y., Qi, C., Calandra, C., Rao, M. S. R., & Reddy, J. K. (1996) · Europe PMC (PubMed Central) · Cited by 178

Up-regulation of ADRP in fatty liver in human and liver steatosis in mice fed with high fat diet

Motomura, W., Inoue, M., Ohtake, T., Takahashi, N., Nagamine, M., Tanno, S., Kohgo, Y., & Okumura, T. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.121 · Cited by 180

Obesity, Peroxisome Proliferator-Activated Receptor, and Atherosclerosis in Type 2 Diabetes

Blaschke, F., Takata, Y., Caglayan, E., Law, R. E., & Hsueh, W. A. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000191663.12164.77 · Cited by 176

PPAR Action in Human Placental Development and Pregnancy and Its Complications

Wieser, F., Waite, L. L., Depoix, C. L., & Taylor, R. N. (2007) · PPAR Research · doi:10.1155/2008/527048 · Cited by 178

Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: relation to insulin action

Loviscach, M., Rehman, N., Carter, L., Mudaliar, S. R. D., Mohadeen, P., Ciaraldi, T. P., Veerkamp, J. H., & Henry, R. R. (2000) · Diabetologia · doi:10.1007/s001250050048 · Cited by 176

Rosiglitazone, a Peroxisome Proliferator-Activated Receptor-γ, Inhibits the Jun NH2-Terminal Kinase/Activating Protein 1 Pathway and Protects the Heart From Ischemia/Reperfusion Injury

Khandoudi, N., Delerive, P., Berrebi-Bertrand, I., Buckingham, R. E., Staels, B., & Bril, A. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1507 · Cited by 174

Peroxisome proliferator-activated receptor ?/? activation inhibits hypertrophy in neonatal rat cardiomyocytes

Planavila, A., Rodríguez‐Calvo, R., Jové, M., Michalik, L., Wahli, W., Laguna, J. C., & Vázquez‐Carrera, M. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.11.011 · Cited by 173

miR‐519d Overexpression Is Associated With Human Obesity

Martinelli, R., Nardelli, C., Pilone, V., Buonomo, T., Liguori, R., Castanò, I., Buono, P., Masone, S., Persico, G., Forestieri, P., et al. (2010) · Obesity · doi:10.1038/oby.2009.474 · Cited by 173

Role of peroxisome proliferator-activated receptor α in disease of pancreatic β cells

Zhou, Y.-T., Shimabukuro, M., Wang, M.-Y., Lee, Y., Higa, M., Milburn, J. L., Newgard, C. B., & Unger, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8898 · Cited by 173

Role of PPARα in mediating the effects of phthalates and metabolites in the liver

Lapinskas, P. J., Brown, S. S., Leesnitzer, L. M., Blanchard, S. G., Swanson, C., Cattley, R. C., & Corton, J. C. (2004) · Toxicology · doi:10.1016/j.tox.2004.09.008 · Cited by 178

Tissue-specific mRNA Expression Profiles of Human Nuclear Receptor Subfamilies

Nishimura, M., Naito, S., & Yokoi, T. (2004) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.19.135 · Cited by 176

PPARα ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats

Toyama, T., Nakamura, H., Harano, Y., Yamauchi, N., Morita, A., Kirishima, T., Minami, M., Itoh, Y., & Okanoue, T. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.110 · Cited by 176

Roles of PPAR delta in lipid absorption and metabolism: a new target for the treatment of type 2 diabetes

Luquet, S., Gaudel, C., Holst, D., Lopez-Soriano, J., Jehl-Pietri, C., Fredenrich, A., & Grimaldi, P. A. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.11.011 · Cited by 210

Variation in the PPARα gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects

Flavell, D. M., Pineda‐Torra, I., Jamshidi, Y., Evans, D., Diamond, J. R., Elkeles, R. S., Bujac, S. R., Miller, G. J., Talmud, P. J., Staels, B., et al. (2000) · Diabetologia · doi:10.1007/s001250051357 · Cited by 171

PPARγ and PGC-1α as Therapeutic Targets in Parkinson’s

Corona, J., & Duchen, M. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1377-0 · Cited by 154

The role of fibric acids in atherosclerosis

Fruchart, J., Staels, B., & Duriez, P. (2001) · Current Atherosclerosis Reports · doi:10.1007/s11883-001-0015-x · Cited by 171

Stimulation of PPARα Promotes Epidermal Keratinocyte Differentiation In Vivo

Kömüves, L. G., Hanley, K., Lefebvre, A., Man, M., Ng, D., Bikle, D. D., Williams, M. L. K., Elias, P. M., Auwerx, J. H., & Feingold, K. R. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00073.x · Cited by 166

Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid

Yang, Q., Abedi‐Valugerdi, M., Xie, Y., Zhao, X., Möller, G., Nelson, B. D., & DePierre, J. W. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00164-3 · Cited by 169

Nuclear Receptor Peroxisome Proliferator-activated Receptor α (PPARα) Is Expressed in Resting Murine Lymphocytes

Jones, D. C., Ding, X., & Daynes, R. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106908200 · Cited by 172

A unique understanding of traditional medicine of pomegranate, Punica granatum L. and its current research status

Ge, S., Duo, L., Wang, J., GegenZhula, Yang, J., Li, Z., & Tu, Y. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113877 · Cited by 168

Thiazolidinediones Increase Plasma-Adipose Tissue FFA Exchange Capacity and Enhance Insulin-Mediated Control of Systemic FFA Availability

Oakes, N. D., Thalén, P., Jacinto, S. M., & Ljung, B. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1158 · Cited by 168

Etomoxir-induced PPARα-modulated enzymes protect during acute renal failure

Portilla, D., Dai, G., Peters, J. M., Gonzalez, F. J., Crew, M. D., & Proia, A. D. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.278.4.f667 · Cited by 168

Peroxisome proliferator-activated receptor gamma is induced during differentiation of colon epithelium cells

Lefebvre, A., Paulweber, B., Lluis Fajas, A., Woods, J. W., McCrary, C. T., Colombel, J. F., Najïb, J., Fruchart, J., Datz, C., Vidal, H., et al. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1620331 · Cited by 167

Regulation of Cyclic AMP Response Element Binding and Hippocampal Plasticity-Related Genes by Peroxisome Proliferator-Activated Receptor α

Roy, A., Jana, M., Corbett, G. T., Ramaswamy, S., Kordower, J. H., Gonzalez, F. J., & Pahan, K. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.07.028 · Cited by 171

PPARα activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats

Diep, Q. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2003.11.004 · Cited by 165

Characterization of the Human PPARα Promoter: Identification of a Functional Nuclear Receptor Response Element

Pineda‐Torra, I., Jamshidi, Y., Flavell, D. M., Fruchart, J., & Staels, B. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.5.0833 · Cited by 169

Identification and Mechanism of 10-Carbon Fatty Acid as Modulating Ligand of Peroxisome Proliferator-activated Receptors

Malapaka, R. R. V., Khoo, S. K., Zhang, J., Choi, J. H., Zhou, X. E., Xu, Y., Gong, Y., Li, J., Yong, E., Chalmers, M. J., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.294785 · Cited by 169

Phthalate ester toxicity in Leydig cells: Developmental timing and dosage considerations

Ge, R.-S., Chen, G.-R., Tanrikut, C., & Hardy, M. P. (2007) · Reproductive Toxicology · doi:10.1016/j.reprotox.2006.12.006 · Cited by 163

Antiinflammatory Roles of Peroxisome Proliferator–activated Receptor γ in Human Alveolar Macrophages

Asada, K., Sasaki, S., Suda, T., Chida, K., & Nakamura, H. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200207-740oc · Cited by 167

Fatty Acid Signaling Mechanisms in Neural Cells: Fatty Acid Receptors

Falomir‐Lockhart, L. J., Cavazzutti, G. F., Giménez, E., & Toscani, A. M. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00162 · Cited by 164

Differential Expression of Peroxisome Proliferator-Activated Receptor Subtypes During the Differentiation of Human Keratinocytes

Rivier, M., Safonova, I., Lebrun, P., Michel, S., Griffiths, C. E. M., & Ailhaud, G. P. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00439.x · Cited by 166

Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney

Yang, T., Michele, D. E., Park, J., Smart, A., Lin, Z., Brosius, F. C., Schnermann, J. B., & Briggs, J. P. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.277.6.f966 · Cited by 160

The PPARβ/δ Activator GW501516 Prevents the Down-Regulation of AMPK Caused by a High-Fat Diet in Liver and Amplifies the PGC-1α-Lipin 1-PPARα Pathway Leading to Increased Fatty Acid Oxidation

Barroso, E., Rodríguez‐Calvo, R., Serrano, L., Astudillo, A. M., Balsinde, J., Palomer, X., & Vázquez‐Carrera, M. (2011) · Endocrinology · doi:10.1210/en.2010-1468 · Cited by 168

Neuronal GDNF Expression in the Adult Rat Nervous System Identified By In Situ Hybridization

Pochon, N. A.-M., Menoud, A., Tseng, J., Zurn, A. D., & Aebischer, P. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01623.x · Cited by 160

A combined1H-NMR spectroscopy- and mass spectrometry-based metabolomic study of the PPAR-α null mutant mouse defines profound systemic changes in metabolism linked to the metabolic syndrome

Atherton, H. J., Bailey, N. J., Zhang, W., Taylor, J., Major, H., Shockcor, J., Clarke, K., & Griffin, J. L. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00060.2006 · Cited by 159

Inhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivo

Dowd, N. P., Scully, M., Adderley, S. R., Cunningham, A. J., & Fitzgerald, D. J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11334 · Cited by 190

Peroxisome proliferator‐activated receptor γ activators inhibit interleukin‐12 production in murine dendritic cells

Faveeuw, C., Fougeray, S., Angéli, V., Fontaine, J., Chinetti, G., Gosset, P., Delerive, P., Maliszewski, C. R., Capron, M., Staels, B., et al. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02319-x · Cited by 160

Inhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivo

Dowd, N. P., Scully, M., Adderley, S. R., Cunningham, A. J., & Fitzgerald, D. J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200111334 · Cited by 159

Molecular targets of vitexin and isovitexin in cancer therapy: a critical review

Ganesan, K., & Xu, B. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13446 · Cited by 160

Physiological functions of peroxisome proliferator-activated receptor β

Neels, J. G., & Grimaldi, P. A. (2014) · Physiological Reviews · doi:10.1152/physrev.00027.2013 · Cited by 161

Pioglitazone attenuates mitochondrial dysfunction, cognitive impairment, cortical tissue loss, and inflammation following traumatic brain injury

Sauerbeck, A. D., Gao, J., Readnower, R. D., Liu, M., Pauly, J. R., Bing, G., & Sullivan, P. G. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.10.003 · Cited by 157

Expression of Peroxisome Proliferator-activated Receptor PPARδ Promotes Induction of PPARγ and Adipocyte Differentiation in 3T3C2 Fibroblasts

Bastie, C. C., Holst, D., Gaillard, D., Jehl-Piétri, C., & Grimaldi, P. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21920 · Cited by 156

Peroxisome Proliferator-Activated Receptor (PPAR)-α Activation Prevents Diabetes in OLETF Rats

Koh, E. H., Kim, M.-S., Park, J., Kim, H. S., Youn, J. Y., Park, H., Youn, J. H., & Lee, K. (2003) · Diabetes · doi:10.2337/diabetes.52.9.2331 · Cited by 156

Peroxisome proliferator activated receptors and obesity

Kersten, S. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01431-0 · Cited by 156

Contrasting effects of fish oil and safflower oil on hepatic peroxisomal and tissue lipid content

Neschen, S., Moore, I. K., Regittnig, W., Yu, C. L., Wang, Y., Pypaert, M., Petersen, K. F., & Shulman, G. I. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00414.2001 · Cited by 155

Adrenoleukodystrophy-Related Protein Can Compensate Functionally for Adrenoleukodystrophy Protein Deficiency (X-ALD): Implications for Therapy

Netik, A., Forss-Petter, S., Holzinger, A., Molzer, B., Unterrainer, G., & Berger, J. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.5.907 · Cited by 148

Novel time-dependent vascular actions of Δ9-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma

O’Sullivan, S. E., Tarling, E. J., Bennett, A. J., Kendall, D. A., & Randall, M. D. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.121 · Cited by 159

More than a store: regulatory roles for glycogen in skeletal muscle adaptation to exercise

Philp, A., Hargreaves, M., & Baar, K. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00004.2012 · Cited by 156

Tie2-mediated loss of peroxisome proliferator-activated receptor-γ in mice causes PDGF receptor-β-dependent pulmonary arterial muscularization

Guignabert, C., Alvira, C. M., Alastalo, T., Sawada, H., Hansmann, G., Zhao, M., Wang, L., El‐Bizri, N., & Rabinovitch, M. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00199.2009 · Cited by 155

The role of peroxisome proliferator-activated receptor-β/δ in epithelial cell growth and differentiation

Burdick, A. D., Kim, D. J., Peraza, M. A., Gonzalez, F. J., & Peters, J. M. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.07.009 · Cited by 156

Pro12Ala Missense Mutation of the Peroxisome Proliferator Activated Receptor γ and Diabetes Mellitus

Ringel, J., Engeli, S., Distler, A., & Sharma, A. M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9962 · Cited by 152

PPAR Alpha as a Metabolic Modulator of the Liver: Role in the Pathogenesis of Nonalcoholic Steatohepatitis (NASH)

Todisco, S., Santarsiero, A., Convertini, P., Stefano, G. D., Gilio, M., Iacobazzi, V., & Infantino, V. (2022) · Biology · doi:10.3390/biology11050792 · Cited by 162

Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.

Touyz, R., & Schiffrin, E. (2006) · Vascular pharmacology · doi:10.1016/j.vph.2005.11.014 · Cited by 158

Effect of Peroxisome Proliferators on Leydig Cell Peripheral-Type Benzodiazepine Receptor Gene Expression, Hormone-Stimulated Cholesterol Transport, and Steroidogenesis: Role of the Peroxisome Proliferator-Activator Receptor

Gazouli, M., Yao, Z., Boujrad, N., Corton, J. C., Culty, M., & Papadopoulos, V. (2002) · Endocrinology · doi:10.1210/endo.143.7.8895 · Cited by 157

PPAR Tissue Distribution and Interactions with Other Hormone‐Signaling Pathwaysa

Lemberger, T., Braissant, O., Juge-Aubry, C. E., KELLER, H., Saladin, R., Staels, B., Auwerx, J. H., Burger, A., Meier, C. A., & Wahli, W. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb18619.x · Cited by 156

Peroxisome Proliferator-Activated Receptors Mediate Host Cell Proinflammatory Responses toPseudomonas aeruginosaAutoinducer

Jahoor, A., Patel, R., Bryan, A., Do, C., Krier, J., Watters, C., Wahli, W., Li, G., Williams, S. C., & Rumbaugh, K. P. (2008) · Journal of Bacteriology · doi:10.1128/jb.01444-07 · Cited by 155

Estrogen Receptor α Binds to Peroxisome Proliferator–Activated Receptor Response Element and Negatively Interferes with Peroxisome Proliferator–Activated Receptor γ Signaling in Breast Cancer Cells

Bonofiglio, D., Gabriele, S., Aquila, S., Catalano, S., Gentile, M., Middea, E., Giordano, F., & Andò, S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2453 · Cited by 151

Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARγ2 in the modulation of insulin secretion

Lupi, R., Guerra, S. D., Marselli, L., Bugliani, M., Boggi, U., Mosca, F., Marchetti, P., & Prato, S. D. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00561.2002 · Cited by 150

Peroxisome Proliferator Activator Receptor-γ Agonists and 15-Deoxy-Δ12,1412,14-PGJ2 Induce Apoptosis in Normal and Malignant B-Lineage Cells

Padilla, J., Kaur, K., Cao, H., Smith, T. J., & Phipps, R. P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.6941 · Cited by 150

Peroxisome Proliferator Activated Receptor

(2006) · Springer eBooks · doi:10.1007/3-540-29719-0_1236

Printed in U.S.A. Copyright © 1998 by The Endocrine Society Differential Expression of Peroxisome Proliferator- Activated Receptor-�,-�, and- � during Rat

Development, E., Braissant, O., & Wahli, W. (2013)

Differential Expression of Peroxisome Proliferator-Activated Receptor- , - , and - during Rat Embryonic Development

Braissant, O., & Wahli, W. (1998) · Endocrinology · doi:10.1210/endo.139.6.6049 · Cited by 457

Prostaglandin and PPAR control of immune cell function

Rotondo, D., & Davidson, J. (2002) · Immunology · doi:10.1046/j.0019-2805.2001.01361.x · Cited by 20

The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation

Schoonjans, K., Staels, B., & Auwerx, J. H. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(96)00066-5 · Cited by 1,045